(19)
(11) EP 4 816 398 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24816921.1

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C07K 16/46(2006.01)
A61P 37/06(2006.01)
C07K 16/18(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2875; C07K 16/18; C07K 2317/622; C07K 2317/55; C07K 2317/76; A61K 2039/505; C07K 2317/24; C07K 2317/64; C07K 2319/31; A61P 37/06; C07K 14/70575
(86) International application number:
PCT/EP2024/083686
(87) International publication number:
WO 2025/114319 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603406 P
01.05.2024 US 202463641087 P

(71) Applicants:
  • H. Lundbeck A/S
    2500 Valby (DK)
  • Aprilbio Co., Ltd
    Chuncheon-si, Gangwon-do 24341 (KR)

(72) Inventors:
  • NOÉ, Francesco, Mattia
    2500 Valby (DK)
  • ASENJO MARTINEZ, Andrea
    2500 Valby (DK)
  • CHA, Sang, Hoon
    Chuncheon-si, Gangwon-do 24318 (KR)
  • SONG, Moo, Young
    Suwon-si, Gyeonggi-do 16532 (KR)
  • ELLIOT, Mark, Stephen, James
    2500 Valby (DK)

(74) Representative: H. Lundbeck A/S 
Ottiliavej 9
2500 Valby
2500 Valby (DK)

   


(54) FUSION PROTEINS FOR USE IN TREATMENT OF THYROID EYE DISEASE